{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:28:02Z","timestamp":1783448882519,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI128364"],"award-info":[{"award-number":["R01AI128364"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI171954"],"award-info":[{"award-number":["U19 AI171954"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007161","name":"Boston University","doi-asserted-by":"publisher","award":["UC7AI095321"],"award-info":[{"award-number":["UC7AI095321"]}],"id":[{"id":"10.13039\/100007161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.slasd.2026.100319","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:12:33Z","timestamp":1781309553000},"page":"100319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In silico prioritization and cheminformatics identify structurally diverse small-molecule inhibitors of Lassa virus glycoprotein-mediated membrane fusion"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-1464","authenticated-orcid":false,"given":"Brianna J","family":"Close","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3304-5892","authenticated-orcid":false,"given":"Cameron","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5796-532X","authenticated-orcid":false,"given":"Manu","family":"Anantpadma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr H","family":"Elkabbany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Hulsey","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1182-0007","authenticated-orcid":false,"given":"Vincent Jo","family":"Davisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-2892","authenticated-orcid":false,"given":"Robert A.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.slasd.2026.100319_bib0001","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3389\/fmicb.2018.01751","article-title":"Review of mammarenavirus biology and replication","volume":"9","author":"Hallam","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.slasd.2026.100319_bib0002","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1038\/s41591-024-03232-y","article-title":"Health and economic impacts of Lassa vaccination campaigns in West Africa","volume":"30","author":"Smith","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.slasd.2026.100319_bib0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12879-021-05837-x","article-title":"Infection pattern, case fatality rate and spread of Lassa virus in Nigeria","volume":"21","author":"Yaro","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.slasd.2026.100319_bib0004","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.slasd.2026.100319_bib0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2016.138","article-title":"Immunobiology of Ebola and Lassa virus infections","volume":"17","author":"Prescott","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.slasd.2026.100319_bib0006","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1752-1947-3-36","article-title":"Sensorineural hearing loss in Lassa fever: two case reports","volume":"3","author":"Okokhere","year":"2009","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.slasd.2026.100319_bib0007","unstructured":"WHO. Prioritizing diseases for research and development in emergency contexts https:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts."},{"key":"10.1016\/j.slasd.2026.100319_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1382953","article-title":"Entry inhibitors as arenavirus antivirals","volume":"15","author":"Iyer","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.slasd.2026.100319_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010289","article-title":"Ribavirin for treating Lassa fever: a systematic review of pre-clinical studies and implications for human dosing","volume":"16","author":"Salam","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.slasd.2026.100319_bib0010","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/microorganisms13061419","article-title":"A review of the epidemiology of Lassa fever in Nigeria","volume":"13","author":"Asogun","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.slasd.2026.100319_bib0011","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cbpa.2009.07.022","article-title":"Determination of glycosylation sites and site-specific heterogeneity in glycoproteins","volume":"13","author":"An","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.slasd.2026.100319_bib0012","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1128\/JVI.00257-16","article-title":"Lassa virus cell entry via dystroglycan involves an unusual pathway of macropinocytosis","volume":"90","author":"Oppliger","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.slasd.2026.100319_bib0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/pathogens8010017","article-title":"Virus\u2212host interactions involved in Lassa Virus entry and genome replication","volume":"8","author":"Loureiro","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.slasd.2026.100319_bib0014","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1038\/s41467-022-31205-7","article-title":"Cell surface glycan engineering reveals that matriglycan alone can recapitulate dystroglycan binding and function","volume":"13","author":"Sheikh","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2026.100319_bib0015","first-page":"1506","article-title":"Lassa virus entry requires a trigger-induced receptor switch","volume":"344","author":"Jae","year":"2014","journal-title":"Science (1979)"},{"key":"10.1016\/j.slasd.2026.100319_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1006\/viro.1994.1057","article-title":"Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike","volume":"198","author":"Di Simone","year":"1994","journal-title":"Virology"},{"issue":"19967\u201319972","key":"10.1016\/j.slasd.2026.100319_bib0017","article-title":"X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation","volume":"108","author":"Igonet","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.slasd.2026.100319_bib0018","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1128\/JVI.00941-08","article-title":"Identification of a broad-spectrum arenavirus entry inhibitor","volume":"82","author":"Larson","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.slasd.2026.100319_bib0019","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"Inglese","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.slasd.2026.100319_bib0020","doi-asserted-by":"crossref","first-page":"18734","DOI":"10.1074\/jbc.M802089200","article-title":"Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses","volume":"283","author":"Lee","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2026.100319_bib0021","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/AAC.00543-16","article-title":"Large-scale screening and identification of novel Ebola virus and Marburg virus entry inhibitors","volume":"60","author":"Anantpadma","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.slasd.2026.100319_bib0022","first-page":"1138","article-title":"NIH Molecular libraries initiative","volume":"306","author":"Austin","year":"2004","journal-title":"Science (1979)"},{"key":"10.1016\/j.slasd.2026.100319_bib0023","unstructured":"National Center for Biotechnology Information. PubChem. PubChem https:\/\/pubchem.ncbi.nlm.nih.gov\/."},{"key":"10.1016\/j.slasd.2026.100319_bib0024","series-title":"ACS Symposium Series","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/bk-2016-1222.ch013","article-title":"The application of cheminformatics in the analysis of high-throughput screening data","volume":"1222","author":"Walters","year":"2016"},{"key":"10.1016\/j.slasd.2026.100319_bib0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acschembio.7b00903","article-title":"Seven year Itch: pan-assay interference compounds (PAINS) in 2017-utility and limitations","volume":"13","author":"Baell","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.slasd.2026.100319_bib0026","unstructured":"Guha, R. & Buonagurio, J. Rpubchem: interface to the PubChem database (2016)."},{"key":"10.1016\/j.slasd.2026.100319_bib0027","unstructured":"Brianna Close & Robert Davey. r-bapchem. 10.5281\/zenodo.18636618 (2026)."},{"key":"10.1016\/j.slasd.2026.100319_bib0028","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/bioinformatics\/btn307","article-title":"ChemmineR: a compound mining framework for R","volume":"24","author":"Cao","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.slasd.2026.100319_bib0029","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1198\/004017002317375064","article-title":"A modification of the Jaccard\u2013Tanimoto Similarity Index for diverse selection of chemical compounds using binary strings","volume":"44","author":"Fligner","year":"2002","journal-title":"Technometrics"},{"key":"10.1016\/j.slasd.2026.100319_bib0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/bioinformatics\/bty633","article-title":"ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R","volume":"35","author":"Paradis","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.slasd.2026.100319_bib0031","first-page":"479","article-title":"Deciphering the glycosylome of dystroglycanopathies using haploid screens for Lassa Virus entry","volume":"340","author":"Jae","year":"2013","journal-title":"Science (1979)"},{"key":"10.1016\/j.slasd.2026.100319_bib0032","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/JVI.01832-09","article-title":"A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry","volume":"84","author":"Wong","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.slasd.2026.100319_bib0033","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","article-title":"Generation of VSV pseudotypes using recombinant \u0394G-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines","volume":"169","author":"Whitt","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.slasd.2026.100319_bib0034","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/microorganisms9010156","article-title":"Automation of infectious focus assay for determination of filovirus titers and direct comparison to plaque and TCID50 assays","volume":"9","author":"Keiser","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.slasd.2026.100319_bib0035","doi-asserted-by":"crossref","unstructured":"Brianna Close & Robert Davey. CellProfiler Pipelines_In silico prioritization and cheminformatics identify structurally diverse small-molecule inhibitors of Lassa virus glycoprotein-mediated membrane fusion. (2026). 10.5281\/zenodo.18866868.","DOI":"10.1016\/j.slasd.2026.100319"},{"key":"10.1016\/j.slasd.2026.100319_bib0036","series-title":"Protein preparation wizard; epik; impact; prime","year":"2025"},{"key":"10.1016\/j.slasd.2026.100319_bib0037","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.slasd.2026.100319_bib0038","series-title":"SiteMap","year":"2025"},{"key":"10.1016\/j.slasd.2026.100319_bib0039","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.slasd.2026.100319_bib0040","series-title":"LigPrep","year":"2025"},{"key":"10.1016\/j.slasd.2026.100319_bib0041","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.slasd.2026.100319_bib0042","series-title":"The Pymol molecular graphics system","year":"2026"},{"key":"10.1016\/j.slasd.2026.100319_bib0043","unstructured":"National Center for Biotechnology Information. PubChem bioassay record for AID 540276. https:\/\/pubchem.ncbi.nlm.nih.gov\/bioassay\/540276."},{"key":"10.1016\/j.slasd.2026.100319_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048476","article-title":"Inside the mind of a medicinal chemist: the role of Human bias in compound prioritization during drug discovery","volume":"7","author":"Kutchukian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.slasd.2026.100319_bib0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s13238-018-0604-x","article-title":"Structure-activity relationship optimization for lassa virus fusion inhibitors targeting the transmembrane domain of GP2","volume":"10","author":"Zhang","year":"2019","journal-title":"Protein Cell"},{"key":"10.1016\/j.slasd.2026.100319_bib0046","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.apsb.2020.02.014","article-title":"Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry","volume":"10","author":"Tang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.slasd.2026.100319_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104701","article-title":"The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein","volume":"174","author":"Zhang","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.slasd.2026.100319_bib0048","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.slasd.2026.100319_bib0049","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.chembiol.2020.08.009","article-title":"Hit triage and validation in phenotypic screening: considerations and strategies","volume":"27","author":"Vincent","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.slasd.2026.100319_bib0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.slasd.2026.100319_bib0051","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1021\/acs.jmedchem.7b00229","article-title":"The ecstasy and agony of assay interference compounds","volume":"60","author":"Aldrich","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.slasd.2026.100319_bib0052","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/acs.jcim.6b00465","article-title":"Phantom PAINS: problems with the utility of alerts for pan-assay INterference CompoundS","volume":"57","author":"Capuzzi","year":"2017","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.slasd.2026.100319_bib0053","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nrd2725","volume":"7","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.slasd.2026.100319_bib0054","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-virology-022221-063725","article-title":"Small-molecule inhibition of viral fusion glycoproteins","volume":"8","author":"Liu","year":"2021","journal-title":"Annu Rev Virol"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:26:25Z","timestamp":1783409185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555226000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S2472555226000250"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100319","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico prioritization and cheminformatics identify structurally diverse small-molecule inhibitors of Lassa virus glycoprotein-mediated membrane fusion","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100319"}}